✦ LIBER ✦

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn’s disease

✍ Scribed by Severine Vermeire; Edouard Louis; An Carbonez; Gert Van Assche; Maja Noman; Jacques Belaiche; Martine De Vos; Andre Van Gossum; Paul Pescatore; Rene Fiasse; Paul Pelckmans; Hendrik Reynaert; Geert D’Haens; Paul Rutgeerts

Book ID: 119392614
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 71 KB
Volume: 97
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(02)04348-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor Necrosis Factor-Alpha Binding Capa

Tumor Necrosis Factor-Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by Fluid-Phase Radioimmunoassays as Predictors of Clinical Efficacy of Infliximab in Crohn's Disease

✍ Ainsworth, Mark A.; Bendtzen, Klaus; Brynskov, Jørn 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 199 KB

PG117 REALWORLD DOSING OF ANTI-TUMOR NEC

PG117 REALWORLD DOSING OF ANTI-TUMOR NECROSIS FACTOR THERAPIES IN THE TREATMENT OF ADULTS WITH CROHN'S DISEASE

✍ H Waters; T Meekins; A Bewtra; RS McKenzie; B Tang; CT Piech; N Papandrikopoulou 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Systematic assessment of factors influen

Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL)

✍ Stephan R. Vavricka; Nicoletta Bentele; Michael Scharl; Gerhard Rogler; Jonas Ze 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Unexpected dramatic clinical response of

Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor (tnfalpha) monoclonal antibody for Crohn’s Disease

✍ Leslie Bank∗; Belinda Hunt 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

Evidence of radiographic benefit of trea

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

✍ J. S. Smolen; C. Han; M. Bala; R. N. Maini; J. R. Kalden; D. van der Heijde; F. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

The effect of monoclonal anti-tumor necr

The effect of monoclonal anti-tumor necrosis factor-antibody cA2 on coagulation- and fibrinolytic parameters in patients with active Crohn's disease: D.W. Hommes, H.M. van Dullemen, J. Meenan, A. van den Ende, J. Woody, G.N.J. Tytgat, S.J.H. van Deventer. Center for Thrombosis, Hemostasis, Atherosclerosis and Inflammation Research, Dept. of Gastroenterology, University of Amsterdam, Amsterdam, the Netherlands

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 177 KB